Inactive Instrument

Shandong Weigao Group Medical Polymer Co Stock HONG KONG GROWTH ENTERPRISES MARKET

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

End-of-day quote HONG KONG GROWTH ENTERPRISES MARKET
- HKD - Intraday chart for Shandong Weigao Group Medical Polymer Co

Financials

Sales 2024 * 14.15B 1.95B 15.27B Sales 2025 * 15.97B 2.21B 17.25B Capitalization 22.59B 3.12B 24.39B
Net income 2024 * 2.2B 303M 2.37B Net income 2025 * 2.65B 365M 2.86B EV / Sales 2024 * 1.12 x
Net cash position 2024 * 6.75B 932M 7.28B Net cash position 2025 * 7.73B 1.07B 8.34B EV / Sales 2025 * 0.93 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
8.47 x
Employees -
Yield 2024 *
3.1%
Yield 2025 *
3.39%
Free-Float 52.98%
More Fundamentals * Assessed data
Weigao Group Logs 28% Decline in 2023 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Weigao Orthopaedic Device's Chairman Resigns MT
Nomura Adjusts Shandong Weigao Group Medical Polymer’s Price Target to HK$8.45 From HK$9.91, Keeps at Buy MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023 CI
Crown International Chairman Resigns; Successor Named MT
Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao to Allot Over 97 Million Shares to Staffers MT
Weigao Group Medical Polymer Slashes Dividend as H1 Profit Declines 16% MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Weigao Flags Up to 19% Fall in H1 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 43 03-07-31
Director of Finance/CFO 46 01-06-30
Chairman 50 05-06-30
Members of the board TitleAgeSince
Chairman 50 05-06-30
Director/Board Member 58 22-09-27
Director/Board Member 52 22-06-05
More insiders
Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Calendar
More about the company